Revising DAS28 scores for remission in rheumatoid arthritis

被引:29
作者
Sheehy, Claire [1 ]
Evans, Verity [1 ]
Hasthorpe, Heather [1 ]
Mukhtyar, Chetan [1 ]
机构
[1] Norfolk & Norwich Univ Hosp, Dept Rheumatol, Norwich, Norfolk, England
关键词
Biological markers; Blood sedimentation; C-reactive protein; Remission; Rheumatoid arthritis; Severity of illness index; C-REACTIVE PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; DISEASE-ACTIVITY SCORE; AMERICAN-COLLEGE; RHEUMATOLOGY/EUROPEAN LEAGUE; CLINICAL-TRIALS; CRITERIA; VALUES;
D O I
10.1007/s10067-013-2468-z
中图分类号
R5 [内科学];
学科分类号
100201 [内科学];
摘要
Current initiatives to treat rheumatoid arthritis (RA) to target remission have resulted in the widespread use of composite outcome measures to quantify disease activity. Simplified Disease Activity Index (SDAI) a parts per thousand currency sign3.3 is the gold standard of remission. Previous work has suggested that the remission threshold of DAS28-ESR or DAS28-CRP a parts per thousand currency sign2.6 is known to be not strict enough and should be revised. There is no previous study that looks at the equivalent DAS28-CRP value that best reflects SDAI remission in a real-life cohort. Consecutive cases fulfilling ACR/EULAR classification criteria for RA from one centre were included if they had an optimum number of visits with recording of all raw data to calculate DAS28-ESR, DAS28-CRP and SDAI. Data from seven visits each of 76 patients, providing 532 data points was examined. Spearman's correlation between DAS28-ESR, DAS28-CRP and SDAI was 0.91-0.97 (p < 0.001). A Bland-Altman plot demonstrated a mean difference of 0.37 units between DAS28-ESR and DAS28-CRP (p < 0.001). ROC and kappa analysis provided values of 2.58 and 2.55 for DAS28-ESR4V and 2.09 and 2.05 for DAS28-CRP4V for SDAI value of 3.3, respectively. The two versions of DAS28 using ESR and CRP and SDAI correlate but are not equivalent or interchangeable for an individual patient. The DAS28-CRP overestimates remission and should be revised downwards to a proposed value of 2.1.
引用
收藏
页码:269 / 272
页数:4
相关论文
共 20 条
[1]
Remission and active disease in rheumatoid arthritis - Defining criteria for disease activity states [J].
Aletaha, D ;
Ward, MM ;
Machold, KP ;
Nell, VPK ;
Stamm, T ;
Smolen, JS .
ARTHRITIS AND RHEUMATISM, 2005, 52 (09) :2625-2636
[2]
2010 Rheumatoid Arthritis Classification Criteria An American College of Rheumatology/European League Against Rheumatism Collaborative Initiative [J].
Aletaha, Daniel ;
Neogi, Tuhina ;
Silman, Alan J. ;
Funovits, Julia ;
Felson, David T. ;
Bingham, Clifton O., III ;
Birnbaum, Neal S. ;
Burmester, Gerd R. ;
Bykerk, Vivian P. ;
Cohen, Marc D. ;
Combe, Bernard ;
Costenbader, Karen H. ;
Dougados, Maxime ;
Emery, Paul ;
Ferraccioli, Gianfranco ;
Hazes, Johanna M. W. ;
Hobbs, Kathryn ;
Huizinga, Tom W. J. ;
Kavanaugh, Arthur ;
Kay, Jonathan ;
Kvien, Tore K. ;
Laing, Timothy ;
Mease, Philip ;
Menard, Henri A. ;
Moreland, Larry W. ;
Naden, Raymond L. ;
Pincus, Theodore ;
Smolen, Josef S. ;
Stanislawska-Biernat, Ewa ;
Symmons, Deborah ;
Tak, Paul P. ;
Upchurch, Katherine S. ;
Vencovsky, Jiri ;
Wolfe, Frederick ;
Hawker, Gillian .
ARTHRITIS AND RHEUMATISM, 2010, 62 (09) :2569-2581
[3]
STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[4]
Castrejón I, 2008, CLIN EXP RHEUMATOL, V26, P769
[5]
Which Measure of Inflammation to Use? A Comparison of Erythrocyte Sedimentation Rate and C-Reactive Protein Measurements from Randomized Clinical Trials of Golimumab in Rheumatoid Arthritis [J].
Crowson, Cynthia S. ;
Rahman, Mahboob U. ;
Matteson, Eric L. .
JOURNAL OF RHEUMATOLOGY, 2009, 36 (08) :1606-1610
[6]
Measuring disease activity and functionality during pregnancy in patients with rheumatoid arthritis [J].
de Man, Yaeal A. ;
Hazes, Johanna M. W. ;
van de Geijn, Fleur E. ;
Krommenhoek, Catharina ;
Dolhain, Radboud J. E. M. .
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH, 2007, 57 (05) :716-722
[7]
American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials [J].
Felson, David T. ;
Smolen, Josef S. ;
Wells, George ;
Zhang, Bin ;
van Tuyl, Lilian H. D. ;
Funovits, Julia ;
Aletaha, Daniel ;
Allaart, Cornelia F. ;
Bathon, Joan ;
Bombardieri, Stefano ;
Brooks, Peter ;
Brown, Andrew ;
Matucci-Cerinic, Marco ;
Choi, Hyon ;
Combe, Bernard ;
de Wit, Maarten ;
Dougados, Maxime ;
Emery, Paul ;
Furst, Daniel ;
Gomez-Reino, Juan ;
Hawker, Gillian ;
Keystone, Edward ;
Khanna, Dinesh ;
Kirwan, John ;
Kvien, Tore K. ;
Landewe, Robert ;
Listing, Joachim ;
Michaud, Kaleb ;
Martin-Mola, Emilio ;
Montie, Pamela ;
Pincus, Theodore ;
Richards, Pamela ;
Siegel, Jeffrey N. ;
Simon, Lee S. ;
Sokka, Tuulikki ;
Strand, Vibeke ;
Tugwell, Peter ;
Tyndall, Alan ;
van der Heijde, Desiree ;
Verstappen, Suzan ;
White, Barbara ;
Wolfe, Frederick ;
Zink, Angela ;
Boers, Maarten .
ARTHRITIS AND RHEUMATISM, 2011, 63 (03) :573-586
[8]
Comparison of Disease Activity Score (DAS) 28-erythrocyte sedimentation rate and DAS28-C-reactive protein threshold values [J].
Inoue, Eisuke ;
Yamanaka, Hisashi ;
Hara, Masako ;
Tomatsu, Taisuke ;
Kamatani, Naoyuki .
ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (03) :407-409
[9]
Association with joint damage and physical functioning of nine composite indices and the 2011 ACR/EULAR remission criteria in rheumatoid arthritis [J].
Klarenbeek, N. B. ;
Koevoets, R. ;
van der Heijde, D. M. F. M. ;
Gerards, A. H. ;
ten Wolde, S. ;
Kerstens, P. J. S. M. ;
Huizinga, T. W. J. ;
Dijkmans, B. A. C. ;
Allaart, C. F. .
ANNALS OF THE RHEUMATIC DISEASES, 2011, 70 (10) :1815-1821
[10]
Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis? [J].
Mäkinen, H ;
Kautiainen, H ;
Hannonen, P ;
Sokka, T .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) :1410-1413